G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2016 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Medical Officer Raj Malik, MD, will present a company overview at the Wedbush PacGrow Healthcare Conference. The presentation will take place on Wednesday, August 17, at 1:55 p.m. ET at the Le Parker Méridien in New York City.

For additional information on the conference, visit:

About G1 Therapeutics, Inc.

G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing G1T28, a potential first-in-class drug candidate, and G1T38, a potential best-in-class compound, in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.

Visit www.g1therapeutics.com for more information.

CONTACT: Contact:                                                               
Gregory Mossinghoff
G1 Therapeutics                                               

Laura Bagby                      
6 Degrees Communications